BioSpace News Archive

2seventy bio, Inc today reported financial results and recent highlights for the second quarter ended June 30, 2023.

Kura Oncology, Inc. today announced the appointment of Brian Powl as Chief Commercial Officer.

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today provided corporate updates and reported its financial results for the quarter ended June 30, 2023.

CNS Pharmaceuticals, Inc. today reported its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterates upcoming milestones.

Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) reports financial results for the three and six months ended June 30, 2023, and provides updates on its antiviral pipeline, upcoming milestones and business activities.

Kelyniam Global, a maker of custom cranial implants, announced results for its half year ended June 30, 2023.

HAPPE Spine announces that the first clinical case with the INTEGRATE®-C Interbody Fusion System was completed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the Beacon Health System – Memorial Hospital in South Bend, Indiana.

Caris Life Sciences® announced that NRG Oncology, a National Cancer Institute National Clinical Trials Network cooperative group, has joined the Caris Precision Oncology Alliance™.

Roivant (Nasdaq: ROIV) today reported its financial results for the first quarter ended June 30, 2023, and provided an update on the business.

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced its financial results for the second quarter ended June 30, 2023, and a strategic reprioritization to strengthen its focus and significantly reduce operating expenses.